TG-43 U1 based dosimetric characterization of model 67-6520 Cs-137 brachytherapy source

Medical Physics

Volumn 36, Issue 10, 2009, Pages 4711-4719

  Meigooni, Ali S ^a,b   Wright, Clarissa ^b   Koona, Rafiq A ^b   Awan, Shahid B ^b   Granero, Domingo ^c   Perez Calatayud, Jose ^d   Ballester, Facundo ^e,f  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f INSTITUTO DE FÍSICA CORPUSCULAR IFIC   (Spain)

Author keywords

Brachytherapy; Cs 137; Dosimetry; GEANT4; PSS model; TG 43

Indexed keywords

ANISOTROPY; FLUORINE COMPOUNDS; LITHIUM COMPOUNDS; MONTE CARLO METHODS; ONCOLOGY; PRODUCT DESIGN; RADIOTHERAPY; RATE CONSTANTS;

BRACHYTHERAPY; CONVOLUTION/SUPERPOSITION; EXPERIMENTAL UNCERTAINTY; GEANT4; LOW DOSE RATE BRACHYTHERAPY; RADIAL DOSE FUNCTION; TG-43; THERMOLUMINESCENT DOSIMETERS;

DOSIMETRY;

ALUMINUM; CESIUM 137; LITHIUM FLUORIDE; STAINLESS STEEL; WATER;

ARTICLE; BRACHYTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOISOTOPE THERAPY; THERMOLUMINESCENCE DOSIMETER; THERMOLUMINESCENCE DOSIMETRY;

EID: 70349656508     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3224462     Document Type: Article

References (35)

1. C. A. Ṕrez and L. W. Brady, Principles and Practice of Radiation Oncology, 3rd ed. (Lippincott Williams and Wilkins, Philadelphia, 1998).
2. D. R. Shearer, Recent Advances in Brachytherapy Physics (American Institute of Physics, New York, 1981).
3. P. W. Grigsby, J. F. Williamson, and C. A. Ṕrez, " Source configuration and dose rates for the Selectron afterloading equipment for ginecologic applicators.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 24, 321-327 (1992).
4. The GEC ESTRO Handbook of Brachytherapy, edited by, A. Gerboulet, R. Poetter, J. -J. Mazeron, H. Meertens, and, E. Van Limbergen, (ESTRO, Leuven, 2002).
5. L. L. Meisberger, R. J. Keller, and R. J. Shalek, " The effective attenuation in water of the gamma rays of gold-198, Ir-192, Cs-137, Ra-226, and Co-60.," Radiology 0033-8419 90, 953-957 (1968).
6. V. Krishnaswamy, " Dose distributions about Cs-137 sources in tissue.," Radiology 0033-8419 105, 181-184 (1972).
7. J. F. Williamson, " Monte Carlo and analytic calculation of absorbed dose near Cs-137 intracavitary sources.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 15, 227-237 (1988).
8. R. Waggener, J. Lange, J. Feldmeier, P. Eagan, and S. Martin, " Cs-137 dosimetry table for asymmetric source.," Med. Phys. 0094-2405 16, 305-308 (1989). 10.1118/1.596424 (Pubitemid 19112065)
9. J. F. Williamson, " Monte Carlo based dose rate tables for the Amersham CDCS.J and 3M Model 6500 Cs-137 tubes.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 41, 959-970 (1998). 10.1016/S0360-3016(98)00150-3 (Pubitemid 28285980)
10. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No.43.," Med. Phys. 0094-2405 22, 209-234 (1995). 10.1118/1.597458
11. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. Saiful Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 0094-2405 31, 663-674 (2004).
12. E. Casal, F. Ballester, J. L. Lluch, J. Perez-Calatayud, and F. Lliso, " Monte Carlo calculations of dose rate distribution around the Amersham CDCS-M-type Cs-137 source.," Med. Phys. 0094-2405 27, 132-140 (2000). 10.1118/1.598875 (Pubitemid 30051921)
13. F. Ballester, J. L. Lluch, Y. Limami, M. A. Serrano, E. Casal, J. Ṕrez-Calatayud, and F. Lliso, " A Monte-Carlo investigation of the dosimetric characteristics of the CSM11 C 137 s source from CIS.," Med. Phys. 0094-2405 27, 2182-2189 (2000). 10.1118/1.1289376 (Pubitemid 30727796)
14. J. Ṕrez-Calatayud, F. Lliso, F. Ballester, M. A. Serrano, J. L. Lluch, Y. Limami, V. Puchades, and E. Casal, " A Monte-Carlo study of dose rate distributions around the specially asymmetric CSM3-a Cs-137 source.," Phys. Med. Biol. 0031-9155 46, N169-N173 (2001). 10.1088/0031-9155/46/7/401 (Pubitemid 32677557)
15. J. Ṕrez-Calatayud, D. Granero, E. Casal, F. Ballester, and V. Puchades, " Monte Carlo and experimental derivation of TG-43 dosimetric parameters for CSM-type Cs-137 sources.," Med. Phys. 0094-2405 32, 28-36 (2005). 10.1118/1.1834835 (Pubitemid 40165512)
16. J. Ṕrez-Calatayud, F. Ballester, J. L. Lluch, M. A. Serrano-Andŕs, E. Casal, V. Puchades, and Y. Limami, " Monte Carlo calculation of dose rate distributions around the Walstam CDC.K-type C 137 s sources.," Phys. Med. Biol. 0031-9155 46, 2029-2040 (2001). 10.1088/0031-9155/46/7/321 (Pubitemid 32677556)
17. 137Cs brachytherapy sources.," Med. Phys. 0094-2405 29, 538-543 (2002). 10.1118/1.1461844 (Pubitemid 34408767)
18. J. Ṕrez-Calatayud, D. Granero, F. Ballester, V. Puchades, and E. Casal, " Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: Evaluation of applicator attenuation and superposition approximation effects.," Med. Phys. 0094-2405 31, 493-499 (2004). 10.1118/1.1644640 (Pubitemid 38381009)
19. L. Liu, S. C. Prasad, and D. A. Bassano, " Determination of Cs-137 dosimetry parameters according to the AAPM TG-43 formalism.," Med. Phys. 0094-2405 31, 477-483 (2004). 10.1118/1.1644519 (Pubitemid 38381007)
20. J. Ṕrez-Calatayud, D. Granero, F. Ballester, E. Casal, R. Cases, and S. Agramunt, " Technical note: Monte Carlo derivation of TG-43 dosimetric parameters for radiation therapy resources and 3M Cs-137 sources.," Med. Phys. 0094-2405 32, 2464-2470 (2005). 10.1118/1.1949748 (Pubitemid 41197183)
21. 125 brachytherapy source.," Med. Phys. 0094-2405 27, 2168-2173 (2000). 10.1118/1.1289256 (Pubitemid 30727794)
22. A. S. Meigooni, Z. Bharucha, M. Yoe-Sein, and K. Sowards, " Dosimetric characteristics of the Best double-wall P 103 d brachytherapy source.," Med. Phys. 0094-2405 28, 2568-2575 (2001). 10.1118/1.1414007 (Pubitemid 34031545)
23. A. S. Meigooni, H. Panth, V. Mishra, and J. F. Williamson, " Instrumentation and dosimeter-size artifacts in quantitative thermoluminescence dosimetry of low-dose fields.," Med. Phys. 0094-2405 22, 555-561 (1995). 10.1118/1.597555
24. S. Agostinelli, " Geant4-a simulation toolkit.," Nucl. Instrum. Methods Phys. Res. A 0168-9002 506, 250-303 (2003) 10.1016/S0168-9002(03)01368- 8; see also http://geant4.web.cern.ch/geant4/.
25. Z. Li, R. K. Das, L. A. DeWerd, G. S. Ibbott, A. S. Meigooni, J. Perez-Calatayud, M. J. Rivard, R. S. Sloboda, and J. F. Williamson, " Dosimetric prerequisites for routine clinical use of photon emitting brachytherapy sources with average energy higher than 50 keV.," Med. Phys. 0094-2405 34, 37-40 (2007). 10.1118/1.2388155 (Pubitemid 46035225)
26. J. Perez-Calatayud, D. Granero, M. Rivard, C. Melhus, M. Pujades, and F. Ballester, " Evaluation of electronic equilibrium conditions near brachytherapy sources.," Med. Phys. 0094-2405 35, 2971 (2008). 10.1118/1.2962843
27. D. Cullen, J. H. Hubbell and L. Kissel, " EPDL97: The evaluated photon data library, '97 version.," Lawrence Livermore National Laboratory Report No. UCRL-LR-50400, 6, Rev. 5 (1997).
28. J. F. Williamson, " Monte Carlo evaluation of kerma at a point for photon transport problems.," Med. Phys. 0094-2405 14, 567-576 (1987). 10.1118/1.596069 (Pubitemid 18012507)
29. A. S. Meigooni, S. B. Awan, N. S. Thompson, and S. A. Dini, " Updated Solid Water to water conversion factors for I 125 and P 103 d brachytherapy sources.," Med. Phys. 0094-2405 33, 3988-3992 (2006). 10.1118/1.2357018 (Pubitemid 44673089)
30. C. S. Melhus and M. J. Rivard, " Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for C 137 s, I 125, I 192 r, P 103 d, and Y 169 b sources.," Med. Phys. 0094-2405 33, 1729-1737 (2006). 10.1118/1.2199987 (Pubitemid 43830261)
31. J. Ṕrez-Calatayud, D. Granero, and F. Ballester, " Phantom size in brachytherapy source dosimetric studies.," Med. Phys. 0094-2405 31, 2075-2081 (2004). 10.1118/1.1759826 (Pubitemid 38924828)
32. K. R. Russell, A. K. Carlsson-Tedgren, and A. Ahnesjö, " Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.," Med. Phys. 0094-2405 32, 2739-2752 (2005). 10.1118/1.1949767 (Pubitemid 41386556)
33. J. F. Williamson, R. S. Baker, and Z. Li, " A convolution algorithm for brachytherapy dose computation in heterogeneous geometries.," Med. Phys. 0094-2405 18, 1256-1265 (1991). 10.1118/1.596601
34. R. E. P. Taylor and D. W. O. Rogers, " EGSnrc Monte Carlo calculated dosimetry parameters for I 192 r and Y 169 b brachytherapy sources.," Med. Phys. 0094-2405 35, 4933-4944 (2008). 10.1118/1.2987676
35. See EPAPS Document No. E-MPHYA6-36-054910 for the numerical values of the parameters and functions of TG-43 U1 formalism for the IPL in EXCEL spreadsheet format. The primary and scatter photon dose contributions as well as the energy-weighted photon spectrum are also provided. For more information on EPAPS, see http://www.aip.org/pubservs/epaps.html.